ATE454383T1 - Neue verbindungen, deren verwendung und herstellung - Google Patents
Neue verbindungen, deren verwendung und herstellungInfo
- Publication number
- ATE454383T1 ATE454383T1 AT03760997T AT03760997T ATE454383T1 AT E454383 T1 ATE454383 T1 AT E454383T1 AT 03760997 T AT03760997 T AT 03760997T AT 03760997 T AT03760997 T AT 03760997T AT E454383 T1 ATE454383 T1 AT E454383T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- new compounds
- compounds
- relates
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 238000007796 conventional method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Dowels (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0201881A SE0201881D0 (sv) | 2002-06-19 | 2002-06-19 | Novel compounds, their use, and preparation |
| US40611902P | 2002-08-26 | 2002-08-26 | |
| SE0202516A SE0202516D0 (sv) | 2002-08-26 | 2002-08-26 | Novel compounds, their use, and preparation |
| US41670102P | 2002-10-07 | 2002-10-07 | |
| PCT/SE2003/001044 WO2004000830A1 (en) | 2002-06-19 | 2003-06-18 | Novel compounds, their use and preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE454383T1 true ATE454383T1 (de) | 2010-01-15 |
Family
ID=30003921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03760997T ATE454383T1 (de) | 2002-06-19 | 2003-06-18 | Neue verbindungen, deren verwendung und herstellung |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1513831B1 (de) |
| JP (1) | JP4460450B2 (de) |
| CN (1) | CN100484933C (de) |
| AT (1) | ATE454383T1 (de) |
| AU (1) | AU2003243089B2 (de) |
| BR (1) | BR0311970A (de) |
| CA (1) | CA2485537A1 (de) |
| DE (1) | DE60330864D1 (de) |
| EA (1) | EA008148B1 (de) |
| HK (1) | HK1079526A1 (de) |
| IL (1) | IL165220A0 (de) |
| MX (1) | MXPA04012711A (de) |
| NO (1) | NO20050270L (de) |
| NZ (1) | NZ536664A (de) |
| WO (1) | WO2004000830A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2004000826A1 (es) | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
| US8685924B2 (en) | 2004-08-25 | 2014-04-01 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
| US9820861B2 (en) | 2007-10-09 | 2017-11-21 | Richard Charles Smith | Rail-fixing implant |
| WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
| AR077094A1 (es) | 2009-06-15 | 2011-08-03 | Takeda Pharmaceutical | Derivados de pirazinooxazepina, composiciones farmaceuticas y su uso en el tratamiento de un sintoma del aparato urinario inferior, obesidad y/o prolapso de organos |
| EP2510949A4 (de) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | Therapeutikum für fibromyalgie |
| WO2012030953A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
| AU2012360905B2 (en) | 2011-12-28 | 2017-04-27 | Janssen Sciences Ireland Uc | Hetero-bicyclic derivatives as HCV inhibitors |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3253989A (en) | 1963-02-11 | 1966-05-31 | American Cyanamid Co | Process for producing anorexia |
| GB1457005A (en) | 1972-11-20 | 1976-12-01 | Pfizer | 2-substituted-3-aminoquinoxalines |
| AR207133A1 (es) | 1973-02-20 | 1976-09-15 | Ciba Geigy Ag | Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano |
| FI193974A (de) | 1973-07-13 | 1975-01-14 | Merck & Co Inc | |
| US4081542A (en) | 1975-04-21 | 1978-03-28 | Merck & Co., Inc. | Piperazinylpyrazines |
| EP0572863A1 (de) | 1992-06-05 | 1993-12-08 | F. Hoffmann-La Roche Ag | ZNS Pyrazinoindole |
| GB9313913D0 (en) | 1993-07-06 | 1993-08-18 | Smithkline Beecham Plc | Novel compounds |
| TW270114B (de) | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| TW334423B (en) | 1993-10-22 | 1998-06-21 | Hoffmann La Roche | Tricyclic 1-aminoethylpyrrole-derivatives |
| FR2722788B1 (fr) | 1994-07-20 | 1996-10-04 | Pf Medicament | Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant |
| CA2201742A1 (en) | 1994-10-13 | 1996-04-25 | Anthony Daniel Piscopio | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists |
| US5688795A (en) | 1994-11-08 | 1997-11-18 | Syntex (U.S.A.) Inc. | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
| FR2740134B1 (fr) | 1995-10-18 | 1998-01-09 | Pf Medicament | Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant |
| JP3560986B2 (ja) | 1997-01-13 | 2004-09-02 | 山之内製薬株式会社 | ５―ｈｔ２ｃ受容体作用薬及びアミノアルキルインダゾール誘導体 |
| WO1998033504A1 (en) | 1997-02-03 | 1998-08-06 | Akzo Nobel N.V. | Treatment of urinary incontinence |
| DE69725113T2 (de) | 1997-02-25 | 2004-07-15 | Akzo Nobel N.V. | Azetidin- und Pyrrolidinderivate |
| FR2761064B1 (fr) | 1997-03-20 | 1999-06-04 | Pf Medicament | Piperazines derivees d'amines cycliques, leur preparation et leur application comme medicaments |
| AU727654B2 (en) | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
| AU8130298A (en) | 1997-07-15 | 1999-02-10 | Sankyo Company Limited | Piperazine derivatives |
| AU4037699A (en) | 1998-05-08 | 1999-11-29 | Akzo Nobel N.V. | Novel aryl-hydro naphthalenal kanamines |
| GB9819032D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds IV |
| GB9819035D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Res Ltd | Chemical compounds VII |
| GB9819033D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds VI |
| GB9819020D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds III |
| GB9819019D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds II |
| GB9820767D0 (en) | 1998-09-23 | 1998-11-18 | Cerebrus Ltd | Chemical compounds VIII |
| US6372745B1 (en) | 1999-12-06 | 2002-04-16 | American Home Products Corporation | 2,3,4,4A-tetrahydro-1H-pyrazino[1,2-A]quinoxalin-5(6H)one derivatives |
| IL143323A0 (en) | 1998-12-17 | 2002-04-21 | American Home Prod | 2,3,4,4a-tetrahydro-1h-pyrazino (1,2-a) quinoxalin-5 (6h) one derivatives being 5ht2c agonists |
| EP1149085A1 (de) | 1999-01-27 | 2001-10-31 | Eli Lilly And Company | Aminoalkylbenzofurane als serotonin-(5-ht(2c))-agonisten |
| GB9902047D0 (en) | 1999-01-29 | 1999-03-17 | Cerebrus Ltd | Chemical compounds XI |
| MXPA01011905A (es) * | 1999-05-21 | 2004-03-19 | Biovitrum Ab | Compuestos novedosos, su uso y preparacion. |
| AU5737900A (en) | 1999-06-15 | 2001-01-02 | Du Pont Pharmaceuticals Company | Substituted heterocycle fused gamma-carbolines |
| ES2209951T3 (es) | 1999-07-29 | 2004-07-01 | Eli Lilly And Company | Benzofuranos serotoninergicos. |
| WO2001009126A1 (en) | 1999-07-29 | 2001-02-08 | Eli Lilly And Company | Serotonergic benzothiophenes |
| PT1204654E (pt) | 1999-07-29 | 2003-11-28 | Lilly Co Eli | Benzofurilpiperazinas agonistas do receptor 5-ht2c da serotonina |
| DE60002583T2 (de) | 1999-07-29 | 2004-03-25 | Eli Lilly And Co., Indianapolis | Benzofurylpiperazine als serotonin-agonisten |
| GB9918962D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxii |
| GB9918965D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxi |
| EP1132389A1 (de) | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | Neue Azaindolyl-Derivate für die Behandlung von Fettleibigheit |
| DK1325008T3 (da) | 2000-07-31 | 2006-02-13 | Hoffmann La Roche | Piperazinderivater |
| AU2001282913A1 (en) | 2000-09-08 | 2002-03-22 | Eli Lilly And Company | A method of treating weight gain associated with atypical antipsychotic use |
| MXPA03003246A (es) | 2000-10-16 | 2003-06-06 | Hoffmann La Roche | Derivados de indolina y su uso como ligandos del receptor 5-ht2. |
| AU2002227170A1 (en) | 2000-11-03 | 2002-05-15 | Wyeth | Cycloalkyl(b)(1,4)diazepino(6,7,1-hi)indoles and derivatives |
| ES2230382T3 (es) | 2000-11-03 | 2005-05-01 | Wyeth | Ciclopental(b)(1,4)diazpino(6,7,1-hi)indoles como antagonistas de 5ht2c. |
| EP1337518B1 (de) * | 2000-11-20 | 2009-06-17 | Biovitrum AB (publ) | Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors |
| CN1267424C (zh) * | 2000-11-20 | 2006-08-02 | 比奥维特罗姆股份公司 | 作为5－羟色胺5ht－2受体的激动剂或拮抗剂的哌嗪基吡嗪化合物 |
| GB0030710D0 (en) | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
| ES2291374T3 (es) | 2000-12-27 | 2008-03-01 | F. Hoffmann-La Roche Ag | Derivados de indol y su empleo como ligandos receptores de 5-ht2b y 5-ht2c. |
| GB0106177D0 (en) | 2001-03-13 | 2001-05-02 | Hoffmann La Roche | Piperazine derivatives |
| US6825198B2 (en) | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
-
2003
- 2003-06-18 CA CA002485537A patent/CA2485537A1/en not_active Abandoned
- 2003-06-18 EA EA200500045A patent/EA008148B1/ru not_active IP Right Cessation
- 2003-06-18 IL IL16522003A patent/IL165220A0/xx unknown
- 2003-06-18 MX MXPA04012711A patent/MXPA04012711A/es not_active Application Discontinuation
- 2003-06-18 DE DE60330864T patent/DE60330864D1/de not_active Expired - Lifetime
- 2003-06-18 EP EP03760997A patent/EP1513831B1/de not_active Expired - Lifetime
- 2003-06-18 JP JP2004530935A patent/JP4460450B2/ja not_active Expired - Fee Related
- 2003-06-18 WO PCT/SE2003/001044 patent/WO2004000830A1/en active Application Filing
- 2003-06-18 NZ NZ536664A patent/NZ536664A/en not_active IP Right Cessation
- 2003-06-18 AU AU2003243089A patent/AU2003243089B2/en not_active Ceased
- 2003-06-18 CN CNB038141310A patent/CN100484933C/zh not_active Expired - Fee Related
- 2003-06-18 BR BR0311970-0A patent/BR0311970A/pt not_active IP Right Cessation
- 2003-06-18 AT AT03760997T patent/ATE454383T1/de not_active IP Right Cessation
-
2005
- 2005-01-17 NO NO20050270A patent/NO20050270L/no not_active Application Discontinuation
- 2005-12-19 HK HK05111675.4A patent/HK1079526A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003243089A1 (en) | 2004-01-06 |
| EP1513831B1 (de) | 2010-01-06 |
| CN100484933C (zh) | 2009-05-06 |
| JP4460450B2 (ja) | 2010-05-12 |
| JP2005532409A (ja) | 2005-10-27 |
| AU2003243089B2 (en) | 2010-01-07 |
| MXPA04012711A (es) | 2005-03-23 |
| EA200500045A1 (ru) | 2005-06-30 |
| NZ536664A (en) | 2007-07-27 |
| EA008148B1 (ru) | 2007-04-27 |
| IL165220A0 (en) | 2005-12-18 |
| CN1662522A (zh) | 2005-08-31 |
| NO20050270L (no) | 2005-01-17 |
| EP1513831A1 (de) | 2005-03-16 |
| DE60330864D1 (de) | 2010-02-25 |
| HK1079526A1 (en) | 2006-04-07 |
| WO2004000830A1 (en) | 2003-12-31 |
| BR0311970A (pt) | 2005-03-29 |
| CA2485537A1 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| SE0301010D0 (sv) | Novel compounds | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| SE0201635D0 (sv) | Novel compounds | |
| ATE318267T1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
| SE0203713D0 (sv) | Novel compounds | |
| DE60131967D1 (de) | Nr1h4-kern-rezeptor-bindende verbindungen | |
| BRPI0410630A (pt) | antagonista de nk1 | |
| RS108404A (en) | Diphenyl azetidinones substituted by acidic groups,method for their production,medicaments containing said compounds and use thereof | |
| ATE413388T1 (de) | Muskarin antagonisten | |
| CY1111327T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος | |
| DE50310161D1 (de) | Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| ATE454383T1 (de) | Neue verbindungen, deren verwendung und herstellung | |
| IL176915A0 (en) | Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
| ATE432278T1 (de) | Verbindungen zur behandlung von krankheiten | |
| GEP20084361B (en) | Piperidinylcarbonyl-pyrro-lidines and their use as melanocortin agonists | |
| ATE543803T1 (de) | 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren | |
| TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
| DE60227421D1 (de) | Rmazeutische zusammensetzung und verwendung davon | |
| DK1373218T3 (da) | Imidazolylderivater til anvendelse som histamin H3-receptorligander | |
| DE602005005967D1 (de) | Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament | |
| DE602004028113D1 (de) | Verwendung von 2,3-Dehydronaringenin-Derivaten zur Behandlung von Entzündungsprozessen und diese Derivate enthaltende pharmazeutische Zusammensetzung | |
| EA200800392A1 (ru) | Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |